文献速递免疫规划传染病防控与疫情报告

肺炎球菌结合疫苗接种对儿童肺炎旁积液影响显著:意大利2006-2018年研究

Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
PubMed 文献 · Vaccine · 2019-04-10

该研究评估了意大利0至16岁儿童在PCV13引入前后12年间肺炎旁积液的病原学、血清型及疫苗接种影响。结果显示PCV13常规免疫显著降低了疫苗接种儿童的PPE负担,且未出现非PCV13血清型增加或血清型替换。

要点

  • PCV13前肺炎链球菌是PPE最常见病原(71.1%),以血清型1、3、7F、19A为主。
  • 0-8岁儿童PPE发病率从PCV13前的2.82降至PCV13后的年龄标化率0.66,p<0.0001。
  • 接种儿童中7F和19A消失,血清型1和3分别下降91.8%和31.5%。

核心结论

  • PCV13常规免疫显著降低了疫苗接种儿童的儿童期PPE负担,未增加其他细菌所致PPE,也未发生血清型替换。
  • 实时PCR是明确PPE病因和监测疫苗接种计划的重要工具。

研究设计与样本

  • 为期12年的研究,评估意大利0至16岁儿童PCV13引入(2011年)前后的PPE病原学和血清型及疫苗接种影响。

主要发现

  • PCV13前,肺炎链球菌是最常见病原(64/90;71.1%),以血清型1(42.4%)、3(23.7%)、7F(5.1%)和19A(11.9%)为主。
  • 基于0-8岁儿童计算,PCV13前PPE发病率为2.82(95%CL 2.32-3.41),PCV13后年龄标化率为0.66(95%CL 0.37-1.99),p<0.0001。
  • 未记录到非PCV13血清型增加。
  • PCV13后,未接种儿童中肺炎链球菌仍最常见,血清型分布不变:1、3、7F、19A分别为26/66(39.4%)、25/66(37.9%)、5/66(7.6%)、4/66(6.1%)。
  • 接种儿童中7F和19A消失,血清型1和3分别下降91.8%和31.5%。

临床怎么用

  • PCV13常规免疫可显著减少疫苗接种儿童的PPE负担,支持继续推进接种。
  • 实时PCR应作为PPE病因诊断和疫苗监测的关键工具。

局限性

  • PCV13的影响可能因意大利肺炎球菌监测增加而被低估。
  • 需更长期研究评估群体保护在PPE预防中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Etiology and serotyping of parapneumonic effusion (PPE) and the impact of vaccination was evaluated over a 12-year period, before and after the PCV13 introduction (2011) for Italian children From 0 to 16 years of age. Five hundred and two children were evaluated; 226 blood and 356 pleural fluid samples were obtained and tested using Realtime-PCR and culture. In the pre-PCV13 era S. pneumoniae was the most frequent pathogen identified (64/90; 71.1%) with a large predominance of serotypes 1 (42.4%), 3 (23.7%), 7F (5.1%) and 19A (11.9%). The impact of vaccination, calculated on children 0-8 years of age, demonstrated a significant reduction of PPE: with an incidence rate of 2.82 (95%CL 2.32-3.41) in the pre-PCV13 era and an age-standardized rate (ASR) of 0.66 (95% CL 0.37-1.99) in the post-PCV13 era, p < 0.0001. No increase in non-PCV13 serotypes was recorded. S. pneumoniae remained the most frequent pathogen identified in the post-PCV13 era in unvaccinated children with an unchanged serotype distribution: respectively 26/66 (39.4%), 25/66 (37.9%), 5/66 (7.6%), and 4/66 (6.1%) for 1, 3, 7F and 19A. On the other hand 7F and 19A disappeared in vaccinated children and serotype 1 and 3 decreased by 91.8% and 31.5%, respectively. Realtime PCR was significantly more sensitive than culture both in pleural fluid (79.7% vs 12.5%) and in blood (17.8% vs 7.4%). In conclusion, our findings indicate that routine immunization with PCV13 has significantly reduced the burden of childhood PPE in vaccinated children, without increasing PPE due to other bacteria and without serotype shift. Moreover, the impact of PCV13 may be underestimated due to the increase in pneumococcal surveillance in Italy. Data has also shown that Real-time PCR is an essential tool to better define the etiology of PPE and to monitor vaccination plans. Longer studies will be necessary to evaluate the role of herd protection in PPE prevention.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Azzari C, Serranti D, Nieddu F, et al. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018. Vaccine. 2019. PMID: 30981627. doi:10.1016/j.vaccine.2019.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。